Polygenic risk score predicts pathologically confirmed cerebral amyloid angiopathy
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70958 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Jung-Min Pyun und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam-si, Gyeonggi-do, Repu…. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Multifactorial Inheritance, Alzheimer Disease. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, National Research Foundation of Korea (Ministry of Science and ICT), Alzheimer's Association.
Abstract (Originalsprache)
INTRODUCTION Cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD) both involve amyloid beta (Aβ) accumulation in vessels and brain parenchyma, respectively. As Aβ‐targeting therapies emerge, CAA draws attention due to its link with amyloid‐related imaging abnormalities (ARIA), underscoring the need for biomarkers beyond magnetic resonance imaging (MRI). METHODS CAA polygenic risk scores (CAA‐PRS) were generated in 105 ADNI participants, and their predictive ability for pathological CAA was evaluated, including in subgroups with high amyloid burden or without MRI‐visible CAA markers. RESULTS CAA‐PRS was significantly associated with pathological CAA (OR = 1.766, p < 0.001), with an AUC of 0.783 overall and 0.766 (OR = 1.780, p = 0.002) in those with high amyloid burden. A marginal association was observed in MRI‐negative individuals. DISCUSSION CAA‐PRS may serve as a complementary biomarker to imaging for identifying high‐risk individuals with CAA, particularly in the context of Aβ‐targeting therapies and ARIA risk. Highlights CAA‐PRS is generated. CAA‐PRS is associated with pathologically confirmed CAA. CAA‐PRS is associated with CAA in individuals with high amyloid burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Seoul National University Bundang Hospital and Seoul National University College of Medicine, Seongnam-si, Gyeonggi-do, Republic of Korea.
- Department of Radiology and Imaging Sciences, and the Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Health Information and Translational Science Building, Indianapolis, Indiana, USA.
Förderung
- NIH HHS
- National Research Foundation of Korea (Ministry of Science and ICT)
- Alzheimer's Association
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Pyun, J. M., Park, Y. H., Kim, S., Nho, K., & Alzheimer's Disease Neuroimaging Initiative (2025). Polygenic risk score predicts pathologically confirmed cerebral amyloid angiopathy. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70958
Vancouver
Pyun JM, Park YH, Kim S, Nho K, Alzheimer's Disease Neuroimaging Initiative. Polygenic risk score predicts pathologically confirmed cerebral amyloid angiopathy. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70958
BibTeX
@article{Pyun2025,
author = {Pyun, Jung-Min and Park, Young Ho and Kim, SangYun and Nho, Kwangsik and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative},
title = {Polygenic risk score predicts pathologically confirmed cerebral amyloid angiopathy},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70958}
}
EUVIMED